Hand Christopher, Adams Malcolm
Prim Care Respir J. 2002 Mar;11(1):9-12. doi: 10.1038/pcrj.2002.5. Epub 2002 Mar 1.
To compare attitudes to illness and treatment with self-reported behaviour in predicting inhaler use in asthmatic patients.
In five practices, 45 patients had their β-2-agonist and steroid inhalers exchanged for Ventolin and Flixotide Accuhalers™. They completed the Illness Perception Questionnaire, the Attitudes to Treatment for Asthma Questionnaire, and a self-report questionnaire at entry, after one month's run-in, and at three months. A nurse counted the number of doses used. Univariate analysis was performed with Accuhaler use over three months as the dependent variable. Independent variables included the questionnaire sub-scales and morbidity. Significant variables were entered into multiple linear regression.
The self-report questionnaire explained 40% of the variance of steroid use. The ATAQ relief sub-scale and morbidity explained 29% of the variance of β-2-agonist use.
Steroid inhaler use can be partly predicted by self-reported behaviour and β-2-agonist use by attitudes to inhaler treatment. These findings have implications for patient education.
比较哮喘患者对疾病和治疗的态度与自我报告行为在预测吸入器使用方面的情况。
在五个医疗机构中，45名患者将其β-2-激动剂和类固醇吸入器换成了万托林和氟替卡松准纳器™。他们在入组时、经过一个月的磨合期后以及三个月时完成了疾病认知问卷、哮喘治疗态度问卷和一份自我报告问卷。一名护士统计了使用的剂量数。以三个月内准纳器的使用情况作为因变量进行单因素分析。自变量包括问卷子量表和发病率。将显著变量纳入多元线性回归。
自我报告问卷解释了类固醇使用差异的40%。ATAQ缓解子量表和发病率解释了β-2-激动剂使用差异的29%。
类固醇吸入器的使用可部分通过自我报告行为来预测，而β-2-激动剂的使用可通过对吸入器治疗的态度来预测。这些发现对患者教育具有启示意义。
